Hero image

We Accelerate Biopharmaceutical 
Asset Development and 
Value Recognition

RRD’s Product Development Team (PDT) partnering model 
defines the right strategy to optimize asset value through 
human proof-of-concept (hPOC) and controls operational 
execution of that strategy for a more predictable achievement 
of value.

Section image

Accelerating the Value
Inflection Point

Nitto selected RRD to create and execute a development strategy for an siRNA therapy. The program resulted in an exclusive worldwide licensing agreement with Bristol-Myers Squibb, a $100M upfront payment and subsequent development milestones and royalties.